Literature DB >> 15791148

Sexual hormones and epilepsy: threat and opportunities.

Andrew G Herzog1, Kristen M Fowler.   

Abstract

PURPOSE OF REVIEW: This article reviews recent developments in our knowledge of the reciprocal interactions between epilepsy and sex hormones and how these interactions may play a role in the pathophysiology and treatment of both. RECENT
FINDINGS: Community studies confirm that menstrual disorders are overrepresented among women with epilepsy, especially among women with high seizure frequency and in those on valproate or polytherapy. Reproductive function is not affected in women with epilepsy who discontinued antiepileptic drug therapy during pubertal maturation. While valproate has been implicated as having particularly notable disruptive effects on reproductive function in women with epilepsy (polycystic ovaries and hyperandrogenemia), this was not evident in non-epileptic primates. The role of epilepsy itself is evident from a study that showed that the laterality of unilateral temporolimbic discharges is associated with predictable directional changes in hormonal secretion at all levels of the reproductive neuroendocrine axis. Epilepsy in men is associated with reduced levels of sexual function, bioactive testosterone and sperm. Various antiepileptic drugs may differ in this regard.
SUMMARY: Epilepsy and antiepileptic drugs can alter sex hormone levels to promote the development of reproductive endocrine disorders in both women and men. Reproductive endocrine disorders may adversely affect both reproductive function and seizure control. Treatment of epilepsy and selection of antiepileptic drugs may be important to reproductive health in women and men with epilepsy. Sex steroids and their metabolites may also provide treatment for seizures.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15791148     DOI: 10.1097/01.wco.0000162859.42218.fd

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  5 in total

1.  Topiramate related reversible erectile dysfunction in temporal lobe epilepsy.

Authors:  Ling-Chien Hung; Julie Chi Chow; Chia-Yen Chang; Jing-Jane Tsai; Chin-Wei Huang
Journal:  Neurol Sci       Date:  2011-07-09       Impact factor: 3.307

Review 2.  Does the type and severity of brain injury predict hypothalamo-pituitary dysfunction? Does post-traumatic hypopituitarism predict worse outcome?

Authors:  M Klose; U Feldt-Rasmussen
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

3.  Harmful effects of carbamazepine on the postnatal development of the rat ventral prostate.

Authors:  Samara U Oliva; Wellerson R Scarano; Fatima K Okada; Sandra M Miraglia
Journal:  Reprod Biol Endocrinol       Date:  2012-03-25       Impact factor: 5.211

Review 4.  Medication Exposures and Subsequent Development of Ewing Sarcoma: A Review of FDA Adverse Event Reports.

Authors:  Judith U Cope; Gregory H Reaman; Joseph M Tonning
Journal:  Sarcoma       Date:  2015-05-07

5.  Interactions of Aromatase and Seladin-1: A Neurosteroidogenic and Gender Perspective.

Authors:  Pelin Kelicen-Ugur; Mehtap Cincioğlu-Palabıyık; Hande Çelik; Hande Karahan
Journal:  Transl Neurosci       Date:  2019-11-06       Impact factor: 1.757

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.